Freestone Grove Partners LP Edwards Lifesciences Corp Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 790,877 shares of EW stock, worth $57.5 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
790,877
Previous 874,714
9.58%
Holding current value
$57.5 Million
Previous $63.4 Billion
2.44%
% of portfolio
0.47%
Previous 0.65%
Shares
3 transactions
Others Institutions Holding EW
# of Institutions
1,445Shares Held
483MCall Options Held
2.76MPut Options Held
1.54M-
Vanguard Group Inc Valley Forge, PA70MShares$5.09 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.7 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$1.86 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY22MShares$1.6 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA19.8MShares$1.44 Billion0.29% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.9B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...